Cooperative Agreement UH3HL154498

Award Date 9/20/20
Completion Date 8/31/25
Dollars Obligated $2.8M
Federal Grant Program
93.837
Assistance Type
Cooperative Agreement
Place of Performance
Nigeria
Similar Awards
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $162,820 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to New York University School of Medicine to leverage community engagement to sustain integrated care models for people living with HIV/AIDS (PLWH) and non-communicable diseases (NCDs) in Nigeria. The key objectives are to: 1) identify barriers and facilitators to developing a community-clinical linkage model for PLWH with hypertension, 2) co-develop a...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $116,748 to Washington University in St. Louis to conduct advanced implementation research and enhance the PI's mentorship capabilities in global cardiovascular patient-oriented research. The key research activities include: 1) Analyzing the impact of team-based care on hypertension control rates in Nigeria, 2) Defining patient retention patterns in hypertension...
This federal Project Grant award for $648,073 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will support a study titled "The ADHINCRA Study: Addressing Hypertension Care in Africa." The study aims to implement and evaluate multilevel interventions, including team-based care and telehealth with home blood pressure monitoring, to improve hypertension control in Ghana and Nigeria. The research will be...
This federal Project Grant award of $633,755.00 from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to develop and implement an integrated community-based approach called "Community Vital Signs (CVS)" to increase rates of blood pressure screening and connections to care for hypertension in Nigeria. The award supports a two-phase project. In the R61 phase (Year 1), the grantee, Oregon Health & Science University, will engage...
This Project Grant award, valued at $118,875, was issued by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The grant aims to externally validate and refine an agent-based model developed during the recipient's prior K01 research. The model simulates the effects of implementation strategies, such as education, audit and feedback, and leadership engagement, on improving the adoption of hypertension care guidelines among...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,321,108 Project Grant under CFDA 93.837 (Cardiovascular Diseases Research) to New York University School of Medicine to conduct transdisciplinary implementation research on a strategy called PT4A. PT4A integrates peer-based medication delivery, peer coaching, and health information technology to improve medication adherence and reduce blood pressure among patients with uncontrolled hypertension in Western Kenya. The study aims to...
This federal Project Grant award of $646,561 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), supports a 16-site, cluster-randomized trial in Uganda to evaluate the impact of a peer-navigation strategy on improving tuberculosis (TB) and TB-HIV treatment adherence and clinical outcomes. The project aims to adapt and implement a multi-component peer-led TB education and adherence counseling intervention, including...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) will provide $2,292,169 to The Johns Hopkins University to conduct a prospective cohort study on integrated proteomic and metabolomic biomarker profiling for understanding metabolic syndrome in pregnant women living with HIV on tenofovir disoproxil fumarate/lamivudine/dolutegravir (TLD) treatment. The study aims to first identify cases of...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $1,566,226 to Research Triangle Institute (RTI International) to evaluate the effectiveness and implementation of a couples-based shared decision-making intervention called CUPID within the Catalyst demonstration project in Uganda. The goal is to improve the uptake, persistence, and adherence of pre-exposure prophylaxis (PrEP) for HIV...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $1,251,196 to the University of Washington to scale up an evidence-based Adolescent Transition Package (ATP) to support transitional care for youth living with HIV in Kenya. The project aims to compare two implementation strategies for scaling up the ATP: the standard Kenya Ministry of Health approach versus an enhanced "ATP-YES" strategy...

MANAGING HYPERTENSION AMONG PEOPLE LIVING WITH HIV: AN INTEGRATED MODEL (MAP-IT) - THIS PROPOSAL IS A COLLABORATION BETWEEN UNIVERSITY OF ABUJA, FHI 360, NEW YORK UNIVERSITY AND SAINT LOUIS UNIVERSITY. ACCESS TO ANTIRETROVIRAL DRUGS HAS LED TO INCREASED SURVIVAL OF PEOPLE LIVING WITH HIV (PLWH), WHO NOW EXPERIENCE HIGHER CVD-MORTALITY THAN THE GENERAL POPULATION, LARGELY DUE TO INCREASED HTN BURDEN. GLOBAL BURDEN OF DISEASE REPORTED A 95% INCREASE IN HTN-RELATED MORTALITY IN NIGERIA FROM 1990 TO 2015. THUS, STRATEGIES TO CONTROL HTN IN PLWH ARE SORELY NEEDED. PHYSICIAN SHORTAGE AND POOR ACCESS LIMIT NIGERIA'S CAPACITY TO CONTROL HTN IN PRIMARY HEALTH CENTERS (PHCS), WHERE MOST PLWH RECEIVE CARE. ACCESS TO CARE AND TASK-SHIFTING OF DUTIES TO NURSES MAY MITIGATE THESE BARRIERS. IN 2011, FHI 360 INITIATED A USAID-FUNDED PROGRAM, STRENGTHENING INTEGRATED DELIVERY OF HIV-AIDS SERVICES (SIDHAS), WHICH PROVIDES UNIVERSAL ACCESS TO HIV SERVICES FOR OVER 190,000 PLWH IN NIGERIA . IN A CLUSTER RCT OF 32 HEALTH CENTERS IN GHANA, WE SHOWED THAT A NURSE-LED TASK-SHIFTING STRATEGY FOR HTN CONTROL (TASSH), BASED ON THE WHO CVD RISK PACKAGE, LED TO A 34% GREATER SYSTOLIC BP REDUCTION THAN HEALTH INSURANCE COVERAGE ALONE (U01HL114198; PI: OGEDEGBE). TASSH INCLUDES CV RISK ASSESSMENT; MEDICATION TITRATION; AND PATIENT LIFESTYLE COUNSELING. THE EXISTENCE OF AN EFFECTIVE HIV CHRONIC ARE PLATFORM (SIDHAS) AND A WELL-PROVEN EVIDENCE-BASED INTERVENTION FOR HTN CONTROL (TASSH) PROVIDES A UNIQUE OPPORTUNITY FOR IMPLEMENTATION OF TASSH AS AN INTEGRATED NCD-HIV MODEL FOR HTN CONTROL IN PLWH. HOWEVER, PHCS IN NIGERIA [WITH ITS WEAK HEALTHCARE SYSTEM] LACK THE EXPERTISE NEEDED TO COORDINATE MULTILEVEL SYSTEM CHANGES. AN IMPLEMENTATION STRATEGY TO OVERCOME THIS BARRIER IS PF VIA PROVISION OF EXTERNAL EXPERTISE AND SUPPORT FOR ADDRESSING CHALLENGES IN IMPLEMENTING EVIDENCE-BASED CARE. ALTHOUGH PF HAS BEEN WIDELY UTILIZED IN HIGH INCOME COUNTRIES, ITS ROLE IN TRANSLATING EBIS INTO ROUTINE PRACTICE IN AFRICA HAS NOT BEEN TESTED. FHI 360'S SIDHAS PROGRAM AND THE 47 PHCS IT SUPPORTS IN AKWA IBOM - [THE STATE WITH THE HIGHEST HIV BURDEN IN NIGERIA] - PROVIDE A VIABLE HIV CHRONIC CARE PLATFORM FOR IMPLEMENTING TASSH AS AN INTEGRATED MODEL FOR HTN CONTROL IN PLWH. WE WILL CONDUCT THIS STUDY IN TWO PHASES USING A MIXED-METHODS DESIGN: 1) A UG3 PLANNING PHASE THAT WILL USE PROMOTING ACTION ON RESEARCH IN HEALTH SERVICES (PARIHS) TO DEVELOP A CONTEXT- SPECIFIC PF STRATEGY TO IMPLEMENT, AND FACILITATE INTEGRATION OF TASSH INTO AN HIV CHRONIC CARE PLATFORM (SIDHAS) FOR MANAGEMENT OF HTN IN PLWH; AND 2) A UH3 IMPLEMENTATION PHASE THAT WILL USE REACH, EFFECTIVENESS, ADOPTION, IMPLEMENTATION AND MAINTENANCE (RE-AIM) TO EVALUATE, IN A STEPPED-WEDGE CLUSTER RCT OF 30 PHCS IN 960 PLWH WITH UNCONTROLLED HTN, THE EFFECT OF PF ON LEVELS OF TASSH ADOPTION (PRIMARY OUTCOME); BP CONTROL (CO-PRIMARY OUTCOME); AND LEVELS OF TASSH SUSTAINMENT (SECONDARY OUTCOME) AT 18 MONTHS. WE WILL ALSO EXAMINE ADOPTION AND IMPLEMENTATION FIDELITY OF TASSH AS POTENTIAL MECHANISMS THAT MAY EXPLAIN THE IMPACT OF PF ON BP CONTROL. THE PF STRATEGY COMPRISES: (A) AN ADVISORY BOARD THAT WILL PROVIDE LEADERSHIP SUPPORT FOR TASSH IMPLEMENTATION; AND (B) TRAINED NURSES (PRACTICE FACILITATORS) WHO WILL SERVE AS COACHES, PROVIDE SUPPORT, KNOWLEDGE EXCHANGE AND PERFORMANCE FEEDBACK TO THE NURSES WHO WILL DELIVER TASSH AT THE PHCS.

Posted 9/15/22, 12:00 AM